Home/Rare Diseases/Fragile X Syndrome

Neurological & Neuromuscular

Fragile X Syndrome

Also called FXS, Martin-Bell Syndrome

Fragile X Syndrome results from expanded CGG trinucleotide repeats in the FMR1 gene on the X chromosome, leading to gene silencing and absence of the fragile X mental retardation protein. This protein plays a critical role in regulating synaptic plasticity and dendritic spine development in the brain.

View active trialsMatch me to a trial

About Fragile X Syndrome

Fragile X Syndrome results from expanded CGG trinucleotide repeats in the FMR1 gene on the X chromosome, leading to gene silencing and absence of the fragile X mental retardation protein. This protein plays a critical role in regulating synaptic plasticity and dendritic spine development in the brain. Males with full mutations typically have moderate to severe intellectual disability, with IQ scores ranging from 20 to 70. Speech is often cluttered and difficult to understand, with echolalia (repeating words or phrases) common. Many individuals develop autism spectrum disorder characteristics. Physical features include a long, narrow face; prominent ears; and distinctive hand features including soft hands with hyperextensible joints. Behavioral issues include hyperactivity, impulsivity, anxiety, and sometimes aggression. Females with full mutations show variable severity, from normal intelligence to moderate disability, depending on X-inactivation patterns.

Common Symptoms

  • Intellectual disability ranging from mild to severe
  • Speech and language delays
  • Autism spectrum behaviors including social anxiety and sensory sensitivities
  • Hyperactivity and attention difficulties
  • Distinctive physical features: large ears, long face, prominent jaw
  • Low muscle tone and joint hypermobility

Who It Affects

Fragile X Syndrome affects males more severely than females, with males often showing intellectual disability and females typically displaying milder learning difficulties. The condition affects all ethnic and racial groups equally. The genetic mutation can be inherited from mothers or arise as new mutations. Females who are carriers may experience symptoms ranging from none to moderate intellectual disability.

Getting Involved in Clinical Trials

Multiple clinical trials are investigating targeted treatments for Fragile X Syndrome, including GABA pathway modulators, mGluR5 antagonists, and approaches targeting synaptic plasticity. Promising research focuses on restoring FMRP function through gene therapy and antisense oligonucleotides. Behavioral and educational interventions remain essential, with trials exploring their optimization in combination with pharmacological approaches. Families should consult their neurologist or geneticist about trial eligibility and the latest treatment advances.

Trusted Sources

Active Clinical Trials for Fragile X Syndrome

Finding trials for Fragile X Syndrome...

Related Neurological & Neuromuscular Conditions

Neurological & Neuromuscular

Duchenne Muscular Dystrophy

Duchenne muscular dystrophy is an X-linked genetic disorder causing progressive muscle weakness and degeneration, beginn...

Neurological & Neuromuscular

Spinal Muscular Atrophy

Spinal muscular atrophy is an autosomal recessive genetic disorder affecting motor neurons in the spinal cord, causing p...

Neurological & Neuromuscular

Myasthenia Gravis

Myasthenia gravis is a chronic autoimmune neuromuscular disorder causing muscle weakness and rapid fatigue. Antibodies a...